These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 27000374)
21. Heat shock protein 72 supports extracellular matrix production in metastatic mammary tumors. Lang BJ; Holton KM; Guerrero-Gimenez ME; Okusha Y; Magahis PT; Shi A; Neguse M; Venkatesh S; Nhu AM; Gestwicki JE; Calderwood SK Cell Stress Chaperones; 2024 Jun; 29(3):456-471. PubMed ID: 38703814 [TBL] [Abstract][Full Text] [Related]
22. Integrated analyses of murine breast cancer models reveal critical parallels with human disease. Rennhack JP; To B; Swiatnicki M; Dulak C; Ogrodzinski MP; Zhang Y; Li C; Bylett E; Ross C; Szczepanek K; Hanrahan W; Jayatissa M; Lunt SY; Hunter K; Andrechek ER Nat Commun; 2019 Jul; 10(1):3261. PubMed ID: 31332182 [TBL] [Abstract][Full Text] [Related]
23. Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer. Wang R; Bhat-Nakshatri P; Padua MB; Prasad MS; Anjanappa M; Jacobson M; Finnearty C; Sefcsik V; McElyea K; Redmond R; Sandusky G; Penthala N; Crooks PA; Liu J; Zimmers T; Nakshatri H Mol Cancer Ther; 2017 Dec; 16(12):2747-2758. PubMed ID: 28978719 [TBL] [Abstract][Full Text] [Related]
24. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth. Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866 [TBL] [Abstract][Full Text] [Related]
25. S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis. Bharadwaj AG; Dahn ML; Liu RZ; Colp P; Thomas LN; Holloway RW; Marignani PA; Too CK; Barnes PJ; Godbout R; Marcato P; Waisman DM Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297495 [TBL] [Abstract][Full Text] [Related]
26. SerpinB2 deficiency is associated with delayed mammary tumor development and decreased pro-tumorigenic macrophage polarization. Piao YJ; Kim HS; Kim H; Shen J; Moon WK BMC Cancer; 2024 Jul; 24(1):792. PubMed ID: 38956496 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042 [TBL] [Abstract][Full Text] [Related]
28. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. Xiong G; Deng L; Zhu J; Rychahou PG; Xu R BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403 [TBL] [Abstract][Full Text] [Related]
29. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Liang L; Hu D; Liu W; Williams JP; Okunieff P; Ding I Am J Clin Oncol; 2003 Aug; 26(4):S114-21. PubMed ID: 12902868 [TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413 [TBL] [Abstract][Full Text] [Related]
31. Dietary Selenium Supplementation Does Not Attenuate Mammary Tumorigenesis-Mediated Bone Loss in Male MMTV-PyMT Mice. Yan L; Nielsen FH; Sundaram S; Cao J Biol Trace Elem Res; 2020 Mar; 194(1):221-227. PubMed ID: 31187394 [TBL] [Abstract][Full Text] [Related]
35. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Berger T; Cheung CC; Elia AJ; Mak TW Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630 [TBL] [Abstract][Full Text] [Related]
36. Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line. Kondreddy VK; Kamatham AN Immunopharmacol Immunotoxicol; 2016; 38(2):153-61. PubMed ID: 26954392 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447 [TBL] [Abstract][Full Text] [Related]
38. B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. Köhler M; Ehrenfeld S; Halbach S; Lauinger M; Burk U; Reischmann N; Cheng S; Spohr C; Uhl FM; Köhler N; Ringwald K; Braun S; Peters C; Zeiser R; Reinheckel T; Brummer T Oncogene; 2019 Feb; 38(8):1324-1339. PubMed ID: 30659267 [TBL] [Abstract][Full Text] [Related]
39. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Chang SH; Liu CH; Conway R; Han DK; Nithipatikom K; Trifan OC; Lane TF; Hla T Proc Natl Acad Sci U S A; 2004 Jan; 101(2):591-6. PubMed ID: 14688410 [TBL] [Abstract][Full Text] [Related]